Geode Capital Management
SHPH icon

Geode Capital Management’s Shuttle Pharmaceuticals SHPH Stock Holding History

Geode Capital Management’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,622
Closed -$31.4K – 4550
2026
Q1 		$31.4K Buy
4,622
+3,178
+220% +$43.1K ﹤0.01% 4399
2025
Q4 		$26K Buy
+1,444
New +$36.9K ﹤0.01% 4350
2025
Q2 		– Sell
-136
Closed -$13.2K – 4510
2025
Q1 		$13.2K Buy
136
+93
+216% +$15.1K ﹤0.01% 4411
2024
Q4 		$9.06K Buy
+43
New +$11.2K ﹤0.01% 4447
2024
Q3 		– Sell
-15
Closed -$12.3K – 4575
2024
Q2 		$12.3K Sell
15
-3
-17% -$2.55K ﹤0.01% 4522
2024
Q1 		$15K Hold
18
– – ﹤0.01% 4514
2023
Q4 		$16.5K Hold
18
– – ﹤0.01% 4546
2023
Q3 		$22.5K Buy
+18
New +$29.7K ﹤0.01% 4598

Other funds holding SHPH

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Geode Capital Management's SHPH Position: Q2 2026 in Review

Geode Capital Management sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2026, closing a stake of 4,622 shares — an estimated $31.4K sold.

Geode Capital Management first reported a position in SHPH in Q3 2023 and held it in 8 quarters. The position peaked at $31.4K in Q1 2026. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

  • Geode Capital Management reported no remaining Shuttle Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 4,622 Shuttle Pharmaceuticals shares in Q2 2026, an estimated $31.4K.
  • Geode Capital Management first reported a position in Shuttle Pharmaceuticals in Q3 2023 and held it in 8 quarters.
  • Geode Capital Management's Shuttle Pharmaceuticals position peaked at $31.4K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.